NCOG-32. THE SAFETY AND EFFICACY OF DEXAMETHASONE IN THE MANAGEMENT OF GLIOMA PATIENTS

Dexamethasone is routinely administered to glioma patients for the management of cerebral edema. Dexamethasone is associated with significant side effects including hyperglycemia, increased risk of infection, and impaired anti-tumor immune response. Despite these risks, there are no standardized gui...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Autores principales: Medikonda, Ravi, Patel, Kisha, Saleh, Laura, Srivastava, Siddhartha, Jackson, Christina, Mohan, Aditya, Weingart, Jon, Bettegowda, Chetan, Gallia, Gary, Brem, Henry, Lim, Michael
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2020
Materias:
Outcome Measures and Neuro-Cognitive Outcomes
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651049/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.570
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares